Tagged: zeclinics

Exclusive: Bioprognos CEO Sergio Calleja Discusses Crowdfunding with Spanish Platform Capital Cell

Bioprognos, a Barcelona-based biotech company that seeks to improve both clinical outcomes and quality of life for cancer patients ―as well as other diseases (cardiovascular, neurological or endocrine)― through the development of innovative tools for non-invasive, accurate detection from biomarkers found in a simple blood… Read More

Catalan BioTech ZeClinics Secures Record Funding on Capital Cell, 2015’s Largest Spanish Biotech Crowdfunded Investment

The Catalan company ZeClinics, supported by the University Pompeu Fabra of Barcelona and and Barcelona Biomedicine Research Park (PRBB) reached its crowdfunding campaign goal  on Capital Cell,  a campaign that set the record for the the year’s largest biotech crowdfunding investment in Spain.  The company is prevalued at 1M€.  After 88… Read More

Send this to a friend